Efficient programming of human eye conjunctiva-derived induced pluripotent stem (ECiPS) cells into definitive endoderm-like cells

Experimental Cell Research

Volumn 322, Issue 1, 2014, Pages 51-61

  Massumi, Mohammad ^a,b,c   Hoveizi, Elham ^d   Baktash, Parvaneh ^a   Hooti, Abdollah ^a   Ghazizadeh, Leili ^a   Nadri, Samad ^b   Pourasgari, Farzaneh ^b,e   Hajarizadeh, Athena ^b   Soleimani, Masoud ^f   Nabiuni, Mohammad ^d   Khorramizadeh, Mohammad R ^g  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

^c UNIVERSITY OF TORONTO   (Canada)

^d KHARAZMI UNIVERSITY   (Iran)

^e Vaccine and Serum Research Institute   (Iran)

^f TARBIAT MODARES UNIVERSITY   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Activin A; Definitive endoderm; IDE1; Induced pluripotent stem cells; Wnt3a

Indexed keywords

ACTIVIN A; CARRIER PROTEIN; GOOSECOID PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3BETA; MESSENGER RNA; PROTEIN IDE1; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG; WNT3A PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL NUCLEUS; CELL SURFACE; CONJUNCTIVA; CYTOPLASM; ENDODERM; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

IPS;

ACTIVIN A; DEFINITIVE ENDODERM; IDE1; INDUCED PLURIPOTENT STEM CELLS; WNT3A;

ACTIVINS; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CONJUNCTIVA; ENDODERM; HEK293 CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; NUCLEAR REPROGRAMMING; WNT3A PROTEIN;

EID: 84893802812     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.01.006     Document Type: Article

References (36)

1. Wobus A.M., Boheler K.R. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 2005, 85:635-678.
2. Piscaglia A.C. Stem cells, a two-edged sword: risks and potentials of regenerative medicine. World J. Gastroenterol. 2008, 14:4273-4279.
3. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
4. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
5. Maehr R., Chen S., Snitow M., Ludwig T., Yagasaki L., Goland R., Leibel R.L., Melton D.A. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15768-15773.
6. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., Isacson O., Jaenisch R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
7. Tan K.Y., Eminli S., Hettmer S., Hochedlinger K., Wagers A.J. Efficient generation of iPS cells from skeletal muscle stem cells. PLoS One 2011, 6:e26406.
8. Aasen T., Belmonte J.C. Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nat. Protoc. 2010, 5:371-382.
9. Nadri S., Soleimani M., Kiani J., Atashi A., Izadpanah R. Multipotent mesenchymal stem cells from adult human eye conjunctiva stromal cells. Differentiation 2008, 76:223-231.
10. Spaide R.F., Ward D.L. Conjunctival biopsy in the diagnosis of sarcoidosis. Br. J. Ophthalmol. 1990, 74:469-471.
11. Caca I., Unlu K., Buyukbayram H., Ari S. Conjunctival deposits as the first sign of systemic sarcoidosis in a pediatric patient. Eur. J. Ophthalmol. 2006, 16:168-170.
12. Moretti A., Bellin M., Jung C.B., Thies T.M., Takashima Y., Bernshausen A., Schiemann M., Fischer S., Moosmang S., Smith A.G., Lam J.T., Laugwitz K.L. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J. 2010, 24:700-711.
13. Saito H., Takeuchi M., Chida K., Miyajima A. Generation of glucose-responsive functional islets with a three-dimensional structure from mouse fetal pancreatic cells and iPS cells in vitro. PLoS One 2011, 6:e28209.
14. Alipio Z., Liao W., Roemer E.J., Waner M., Fink L.M., Ward D.C., Ma Y. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13426-13431.
15. Spence J.R., Wells J.M. Translational embryology: using embryonic principles to generate pancreatic endocrine cells from embryonic stem cells. Dev. Dyn. 2007, 236:3218-3227.
16. Sherwood R.I., Jitianu C., Cleaver O., Shaywitz D.A., Lamenzo J.O., Chen A.E., Golub T.R., Melton D.A. Prospective isolation and global gene expression analysis of definitive and visceral endoderm. Dev. Biol. 2007, 304:541-555.
17. Semb H. Definitive endoderm: a key step in coaxing human embryonic stem cells into transplantable beta-cells. Biochem. Soc. Trans. 2008, 36:272-275.
18. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., Young H., Richardson M., Smart N.G., Cunningham J., Agulnick A.D., D'Amour K.A., Carpenter M.K., Baetge E.E. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008, 26:443-452.
19. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., Moorman M.A., Kroon E., Carpenter M.K., Baetge E.E. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24:1392-1401.
20. Hebrok M., Kim S.K., Melton D.A. Notochord repression of endodermal sonic hedgehog permits pancreas development. Genes Dev. 1998, 12:1705-1713.
21. Vincent S.D., Dunn N.R., Hayashi S., Norris D.P., Robertson E.J. Cell fate decisions within the mouse organizer are governed by graded Nodal signals. Genes Dev. 2003, 17:1646-1662.
22. Naujok O., Burns C., Jones P.M., Lenzen S. Insulin-producing surrogate beta-cells from embryonic stem cells: are we there yetα. Mol. Ther. 2011.
23. Habener J.F., Kemp D.M., Thomas M.K. Minireview: Transcriptional regulation in pancreatic development. Endocrinology 2005, 146:1025-1034.
24. Nostro M.C., Sarangi F., Ogawa S., Holtzinger A., Corneo B., Li X., Micallef S.J., Park I.H., Basford C., Wheeler M.B., Daley G.Q., Elefanty A.G., Stanley E.G., Keller G. Stage-specific signaling through TGFbeta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 2011, 138:861-871.
25. Murtaugh L.C., Law A.C., Dor Y., Melton D.A. Beta-catenin is essential for pancreatic acinar but not islet development. Development 2005, 132:4663-4674.
26. Lickert H., Kispert A., Kutsch S., Kemler R. Expression patterns of Wnt genes in mouse gut development. Mech Dev 2001, 105:181-184.
27. Toivonen S., Lundin K., Balboa D., Ustinov J., Tamminen K., Palgi J., Trokovic R., Tuuri T., Otonkoski T. Activin A and Wnt-dependent specification of human definitive endoderm cells. Exp. Cell Res. 2013, 319:2535-2544.
28. McLean A.B., D'Amour K.A., Krishnamoorthy J.K.L., K.M.J.M., Reynolds D.M., Sheppard A.M., LIU H., Xu Y., Baetge E.E., Dalton S. Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells 2007, 25:29-38.
29. D'Amour K.A., Agulnick A.D., Eliazer S., Kelly O.G., Kroon E., Baetge E.E. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 2005, 23:1534-1541.
30. Borowiak M., Maehr R., Chen S., Chen A.E., Tang W., Fox J.L., Schreiber S.L., Melton D.A. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Cell Stem Cell 2009, 4:348-358.
31. Taura D., Noguchi M., Sone M., Hosoda K., Mori E., Okada Y., Takahashi K., Homma K., Oyamada N., Inuzuka M., Sonoyama T., Ebihara K., Tamura N., Itoh H., Suemori H., Nakatsuji N., Okano H., Yamanaka S., Nakao K. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett. 2009, 583:1029-1033.
32. Ludwig T.E., Levenstein M.E., Jones J.M., Berggren W.T., Mitchen E.R., Frane J.L., Crandall L.J., Daigh C.A., Conard K.R., Piekarczyk M.S., Llanas R.A., Thomson J.A. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 2006, 24:185-187.
33. Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J., Lin J.K., Farzadfar F., Khang Y.H., Stevens G.A., Rao M., Ali M.K., Riley L.M., Robinson C.A., Ezzati M. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011, 378:31-40.
34. Farney A.C., Cho E., Schweitzer E.J., Dunkin B., Philosophe B., Colonna J., Jacobs S., Jarrell B., Flowers J.L., Bartlett S.T. Simultaneous cadaver pancreas living-donor kidney transplantation: a new approach for the type 1 diabetic uremic patient. Ann. Surg. 2000, 232:696-703.
35. Burra P., Bizzaro D., Ciccocioppo R., Marra F., Piscaglia A.C., Porretti L., Gasbarrini A., Russo F.P. Therapeutic application of stem cells in gastroenterology: an up-date. World J. Gastroenterol. 2011, 17:3870-3880.
36. Aguayo-Mazzucato C., Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2010, 6:139-148.